SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN)
BTRN 35.410.0%Nov 26 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sim1 who wrote (735)9/13/2000 7:05:59 PM
From: scaram(o)uche  Read Replies (1) of 1475
 
but the relevant antigens
(tumor-specific antigens, the recipient's histocompatibility antigens, or both) have not been identified.

Some of the GvH rats in my study survived leukemia challenge. When those animals were again challenged with the same spontaneous leukemia (which I had isolated and frozen down, in large quantity, after only a single passage in a Lewis rat), they died at the same time as age-matched controls. This argues -- not strongly, by any means -- against "tumor-specific".
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News